PHIO icon

Phio Pharmaceuticals
PHIO

11 hedge funds and large institutions have $387K invested in Phio Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$114K
2
+$37.9K
3
+$34K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$8K
5
SS
SBI Securities
Japan
+$2.21K

Top Sellers

1
-$14.1K
2
-$14K
3
-$3.25K
4
UBS Group
UBS Group
Switzerland
-$134
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$136K
Vanguard Group
2
Vanguard Group
Pennsylvania
$114K
Cetera Investment Advisers
3
Cetera Investment Advisers
Illinois
$76.4K
VF
4
Virtu Financial
New York
$34K
Morgan Stanley
5
Morgan Stanley
New York
$14.1K
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$8K
SS
7
SBI Securities
Japan
$4.49K
AssetMark Inc
8
AssetMark Inc
California
$259
Bank of America
9
Bank of America
North Carolina
$108
MYIA
10
Mount Yale Investment Advisors
Colorado
$63
AWM
11
Activest Wealth Management
Florida
$21
XT
12
XTX Topco
Cayman Islands
–
TRCT
13
Tower Research Capital (TRC)
New York
–
UBS Group
14
UBS Group
Switzerland
–